Novo Nordisk is investing $409 million in a new state-of-the-art quality control laboratory in Hillerød, Denmark. The new facility, covering 53,000 square meters, will be the company’s largest investment in advanced quality control to date.    The new lab will serve as a central hub for quality control operations in Denmark, consolidating existing locations into a world-class facility. It is designed to comply with the demands of current and future Good Manufacturing Practice (GMP) and will su...